Monoamine Oxidase as a Potential Biomarker of the Efficacy of Treatment of Mental Disorders
М. Г. Узбеков
Abstract
The review summarizes the results of our own studies and published data on the biological markers of psychiatric disorders, with special emphasis on the activity of platelet monoamine oxidase. Pharmacotherapy studies in patients with the mixed anxiety-depressive disorder and first episode of schizophrenia have shown that the activity of platelet monoamine oxidase could serve as a potential biomarker of the efficacy of therapeutic interventions in these diseases.
Topics & Concepts
Monoamine oxidaseBiomarkerSchizophrenia (object-oriented programming)PsychiatryMonoamine neurotransmitterMedicineAnxietyMonoamine oxidase inhibitorPharmacotherapyPharmacologyPsychologySerotoninInternal medicineBiologyEnzymeReceptorBiochemistryTryptophan and brain disordersBipolar Disorder and TreatmentTreatment of Major Depression